Constellation Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$570K Buy
30,303
+800
+3% +$14.1K 0.1% 209
2015
Q4
$544K Buy
29,503
+600
+2% +$10.8K 0.1% 216
2015
Q3
$474K Buy
28,903
+100
+0.3% +$1.71K 0.1% 235
2015
Q2
$510K Buy
28,803
+600
+2% +$10.7K 0.1% 228
2015
Q1
$501K Buy
28,203
+1,300
+5% +$20.5K 0.1% 238
2014
Q4
$356K Buy
26,903
+1,200
+5% +$15.3K 0.07% 302
2014
Q3
$304K Buy
25,703
+500
+2% +$6.3K 0.07% 308
2014
Q2
$322K Buy
25,203
+400
+2% +$5.2K 0.07% 296
2014
Q1
$335K Buy
24,803
+300
+1% +$3.94K 0.08% 275
2013
Q4
$295K Buy
24,503
+1,600
+7% +$18.9K 0.08% 288
2013
Q3
$269K Buy
22,903
+1,300
+6% +$14.1K 0.08% 274
2013
Q2
$200K Buy
+21,603
New +$183K 0.07% 321

Other funds holding BSX

Constellation Investments's BSX Position: Q1 2016 in Review

Constellation Investments increased its Boston Scientific (BSX) stake by 2.7% in Q1 2016, buying an estimated $14.1K and bringing the position to 30,303 shares worth $570K. The position accounts for 0.1% of the portfolio, ranked #209.

Constellation Investments first reported a position in BSX in Q2 2013 and has held it in 12 quarters since. 493 funds tracked by Wall St. Rank hold BSX as of Q1 2016.

  • Constellation Investments held 30,303 shares of Boston Scientific worth $570K as of Q1 2016.
  • Constellation Investments bought 800 Boston Scientific shares in Q1 2016, an estimated $14.1K.
  • Boston Scientific made up 0.1% of Constellation Investments's portfolio in Q1 2016, its #209 holding.
  • Constellation Investments first reported a position in Boston Scientific in Q2 2013 and has held it in 12 quarters since.
  • 493 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.